drugset / Trial / NCT02297906
Pharmacokinetics of Intranasal Ketorolac in Children
RandomizedParallel-groupOpen-labelTreatment
Summary
Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) that is typically given to both adults and children by the intravenous (IV) or intramuscular (IM) route for analgesic purposes. Ketorolac can also be given by the intranasal (IN) route using a mucosal atomization device (MAD). We aim to study the pharmacokinetics of ketorolac when administered by the IN route using the MAD.
Timeline
- Start
- 2015-02
- Primary completion
- 2017-11-29
- Completion
- 2017-11-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketorolac | Other / unclassified | 0.5 mg/kg | Intranasal |
Indications
No indication recorded.